TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Smart & Final (SFS) Stock Closed Lower, Downgraded at Morgan Stanley
MARKETS

Celladon (CLDN) Stock Popping on Eiger Merger

Alder BioPharmaceuticals: Cramer's Top Takeaways
STOCKS

Spark Tries to Quell Investor Fears About Gene Therapy Test

Facebook's Earnings Show Best Is Yet to Come: What Wall Street Is Saying
STOCKS

5 Stocks With Ominous Insider Selling as Market Took Painful Turn

5 Best-Positioned Biotech Stocks on Brexit Volatility
OPINION

10 Worst Biotech Stocks in the NASDAQ

Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Celladon (CLDN) Stock Tanks on Possible Liquidation

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

PTC Therapeutics (PTCT) Stock Upgraded at Jefferies
OPINION

4 Breakout Biotech Stocks Under $10 to Watch

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Avalanche Fails Common-Sense Test, Kicked Out of Gene Therapy Credibility Club

Dating Sites: Best, Worst & Weirdest
OPINION

3 Stocks Under $10 Triggering Breakout Trades

Continental Resources (CLR) Stock Rises Today as Oil Prices Rally
MARKETS

Celladon (CLDN) Stock Rises After Announcing Strategic Acquisition Plan

Don't Panic! Despite First-Quarter Fears, U.S. Economic Expansion Won't End Soon
MARKETS

Nasdaq Backs Off Record High as Biotech Drags Markets Lower

The Royal Wedding: Photo Slideshow
MARKETS

Biotech Drags on Stocks; Crude Oil Drops Below $57

Pan American Silver (PAAS) Stock Gains on Heavy Trading Volume
MARKETS

Celladon (CLDN) Stock Lower Today on Negative Heart Failure Treatment Test Results

Google Slips on Patent Program; Tesla Leads Nasdaq Ahead of Battery Presentation
VIDEO

Google Slips on Patent Program; Tesla Leads Nasdaq Ahead of Battery Presentation

Jim Cramer -- Stay Bullish on Netflix, Learn From Celladon
OPINION

Jim Cramer -- Stay Bullish on Netflix, Learn From Celladon

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Post Modest Gains; Apple Jumps Ahead of Earnings

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial

5 Stocks Insiders Love Right Now
INVESTING

5 Stocks Set to Soar on Bullish Earnings

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Celladon Heart-Failure Study Looms Large as Next Big Test for Gene Therapy

'Mad Money' Lightning Round: Take General Mills Over Kellogg
JIM CRAMER

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

GoPro's Revenue Fuels Concern About Market Saturation
INVESTING

14 IPOs You Wish You Bought in 2014 (and Made a Killing On)

5 Bargain Bin Stocks to Buy in March
INVESTING

5 Stocks Moving on Unusual Volume

4 Stocks Under $10 Making Big Moves
INVESTING

4 Stocks Breaking Out on Big Volume

Dating Sites: Best, Worst & Weirdest
STOCKS

Celadon Group Inc. Q4 2010 Earnings Call Transcript